BTC$60,315.00+1.71%
ETH$1,582.14+2.36%
USDT$0.9985+0.00%
BNB$563.49+0.02%
USDC$0.9997+0.01%
XRP$1.06+2.94%
SOL$71.86+4.55%
TRX$0.3207-0.34%
FIGR_HELOC$1.03-0.47%
HYPE$63.17+1.77%
DOGE$0.0752+2.10%
USDS$0.9998+0.03%
RAIN$0.0156-0.32%
LEO$9.37+1.97%
ZEC$409.14+3.45%
XMR$317.57+3.46%
BTC$60,315.00+1.71%
ETH$1,582.14+2.36%
USDT$0.9985+0.00%
BNB$563.49+0.02%
USDC$0.9997+0.01%
XRP$1.06+2.94%
SOL$71.86+4.55%
TRX$0.3207-0.34%
FIGR_HELOC$1.03-0.47%
HYPE$63.17+1.77%
DOGE$0.0752+2.10%
USDS$0.9998+0.03%
RAIN$0.0156-0.32%
LEO$9.37+1.97%
ZEC$409.14+3.45%
XMR$317.57+3.46%
Circle’s Q3 earnings report underscores how stablecoins are becoming silent engines of U.S. financial power - embedding globally in a profitable and compliant manner.
TradeZero launches TZ1, a web-based trading platform featuring TradingView integration, customizable workspaces, and advanced tools designed for active traders.
IBM stock gained after it introduced Quantum Nighthawk, a new 120-qubit processor that marks its most advanced quantum chip so far.
Pfizer’s comeback, Newmont’s resilience, and Utz’s growth positioning make them compelling candidates for year-end gains.
AMD stock rose 5.27% in premarket trading after the company forecast more than 35% annual sales growth over the next 3–5 years, driven by strong demand…
CoreWeave cut its 2025 revenue outlook by $150 million and slashed capex by $8.5 billion due to data center delays, sending shares down 8.6% in premarket…
Nvidia shares traded lower in premarket as SoftBank exited its $5.8 billion position to bankroll Son’s AI strategy, redirecting cash toward OpenAI and major data center…
After a sharp valuation drop, Duolingo’s future hinges on its AI-first expansion and whether its gamified learning model can outlast direct AI tutoring.
BigBear.ai shares climbed nearly 19% in premarket after strong Q3 results and the $250 million Ask Sage acquisition.
Centene shares slid 9% after Trump called for ACA funding to go directly to individuals rather than insurance companies.
Cogent Biosciences stock jumped 120% after positive Phase 3 PEAK trial results for its GIST drug bezuclastinib.
Novo Nordisk stock jumped 4% in premarket after withdrawing from the Metsera bidding war, clearing the way for Pfizer's $10 billion acquisition.
Navitas Semiconductor stock fell over 13% after announcing a $100 million private placement at $6.75 per share, triggering investor concern over dilution.